[3MS-12] 【J】Cutting-edge human disease research based on large-scale biobanks in Japan | The 48th Annual Meeting of the Molecular Biology Society of Japan

The 48th Annual Meeting of the Molecular Biology Society of Japan

Session Details

Mini-Symposia

[3MS-12]【J】Cutting-edge human disease research based on large-scale biobanks in Japan

Fri. Dec 5, 2025 11:15 AM - 12:35 PM JST
Fri. Dec 5, 2025 2:15 AM - 3:35 AM UTC

Room 12(Pacifico Yokohama Conference Center 4F, 416+417)

Organizer: Takahiro Nobukuni (Tohoku University), Yu-ichi Goto (National Center of Neurology and Psychiatry)

To develop the cure for diseases it is critical to prove the concept derived from laboratory animals by using human specimens. To that end large-scale biobanks have been founded which accumulate and provide human biospecimen and information as well as analytical data such as genome sequences. By presenting cutting-edge projects that made use of these resources, we aim to widen the application of molecular studies to clinical settings.

11:15 AM - 11:21 AM JST(2:15 AM - 2:21 AM UTC)

[3MS-12-01]Why we should use biobanks. Intorduction to the symposium.

○Takahiro Nobukuni¹ (1. Tohoku University)

Comment()

11:21 AM - 11:27 AM JST(2:21 AM - 2:27 AM UTC)

[3MS-12-02]Benefits and know-how of using human disease tissue/organ biobanks: Introduction

○Yu-ichi Goto^1,2 (1. National Center of Neurology and Psychiatry, 2. Japan Institute for Health Security)

Comment()

11:27 AM - 11:44 AM JST(2:27 AM - 2:44 AM UTC)

[3MS-12-03]Quality control of biobank samples and the strength of sample utilization research: from pathologists’ perspective

○Yae Kanai¹ (1. Department of Pathology, Keio University School of Medicine)

Comment()

11:44 AM - 12:01 PM JST(2:44 AM - 3:01 AM UTC)

[3MS-12-04]Utilizing human post-mortem brain resources for research into neurological and psychiatric disorders

○Mari Tada¹ (1. Brain Research Institute, Niigata University)

Comment()

12:01 PM - 12:18 PM JST(3:01 AM - 3:18 AM UTC)

[3MS-12-05]Comprehensive immunogenomic analysis of autoimmune diseases leveraging a large-scale biobank

○Kazuyoshi Ishigaki^1,2,3 (1. Keio University School of Medicine, 2. Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q), 3. RIKEN Center for Integrative Medical Sciences)

Comment()

12:18 PM - 12:35 PM JST(3:18 AM - 3:35 AM UTC)

[3MS-12-06]Development of novel diagnostic biomarkers for intractable kidney diseases using iPS cell-based disease models and large biobanks

○Kenji Osafune¹ (1. Kyoto University)

Comment()

Back to Category List